📊 Score Breakdown
Offering Ability
60
Cash Runway
65
Float Risk
47
Warrant Exposure
30
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
32%
📉 Score Deterioration
50%
• Score rose 39 points recently (worsening)
• Score in HIGH risk zone (63/100)
💰 Capital Raise
15%
• Under 12 months cash (7mo)
📜 Warrant Exercise
15%
• Warrant overhang: 6.9% of shares outstanding
💹 Market Data
Market Cap$31.60M
Shares Outstanding14.49M
Float7.23M
Cash$2.43M
Debt$4.10M
Short InterestN/A
🏛 Institutional Holdings
15 institutional holders · 1.12M shares
#1
ARMISTICE CAPITAL, LLC
1.00M shares
#2
VANGUARD GROUP INC
43.7K shares
#3
GEODE CAPITAL MANAGEMENT, LLC
39.9K shares
+ 12 more holders Sign up free to view →
📉 Short Interest
Short Interest58.7K
Days to Cover1.5
% of Float0.8%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Feb 28, 2026
xbrl
XBRL CONVERTIBLE
Feb 28, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NTRP
📊 NTRP FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NTRP Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.